切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2017, Vol. 13 ›› Issue (05) : 503 -510. doi: 10.3877/cma.j.issn.1673-5250.2017.05.002

所属专题: 文献

述评

妊娠期甲状腺疾病及其相关诊断指标的参考值范围研究现状
王国成1, 麻伟博2, 孙红敏2, 冯国双3,()   
  1. 1. 101300 北京市顺义区妇幼保健院,北京儿童医院顺义妇儿医院临床检验中心
    2. 101300 北京市顺义区妇幼保健院,北京儿童医院顺义妇儿医院妇产科
    3. 100045 首都医科大学附属北京儿童医院临床流行病学与循证医学中心
  • 收稿日期:2017-03-20 修回日期:2017-08-22 出版日期:2017-10-01
  • 通信作者: 冯国双

Research status of gestational thyroid diseases and reference ranges of related diagnostic indexes

Guocheng Wang1, Weibo Ma2, Hongmin Sun2, Guoshuang Feng3,()   

  1. 1. Department of Clinical Laboratory
    2. Department of Gynecology and Obstetrics, Shunyi Women and Children′s Hospital of Beijing Children′s Hospital, Beijing 101300, China
    3. Center for Clinical Epidemiology and Evidence-based Medicine, Beijing Children′s Hospital, Capital Medical University, Beijing 100045, China
  • Received:2017-03-20 Revised:2017-08-22 Published:2017-10-01
  • Corresponding author: Guoshuang Feng
  • About author:
    Corresponding author: Feng Guoshuang, Email:
引用本文:

王国成, 麻伟博, 孙红敏, 冯国双. 妊娠期甲状腺疾病及其相关诊断指标的参考值范围研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2017, 13(05): 503-510.

Guocheng Wang, Weibo Ma, Hongmin Sun, Guoshuang Feng. Research status of gestational thyroid diseases and reference ranges of related diagnostic indexes[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2017, 13(05): 503-510.

妊娠期甲状腺疾病已迅速成为孕妇的常见疾病之一。究其原因,与妊娠前和妊娠期检查手段的增多、检查范围扩大及人群碘营养状态改变等有关。妊娠过程中,母体血清人绒毛膜促性腺激素(hCG)、雌激素水平上升,血容量增加和肾小球滤过功能增强等一系列生理变化,均对甲状腺功能,甲状腺激素合成、分泌、排泄产生重大影响。血清甲状腺激素水平异常、甲状腺功能紊乱,可导致不良妊娠结局,引起自然流产、早产,甚至死胎等。甲状腺激素在胎儿脑组织神经元迁移和髓鞘形成过程中不可或缺。妊娠期甲状腺素缺乏性疾病包括临床明显甲状腺功能减退(OH)、亚临床甲状腺功能减退(SCH)、单纯性低甲状腺素血症(IH),这些均可导致子代神经系统发育缺陷、智力发育异常。妊娠期甲状腺疾病早期或亚临床甲状腺疾病时,临床症状、体征缺乏特异性表现,常与妊娠生理性表现重叠,而难以被临床诊断。因此,妊娠期甲状腺疾病相关实验室检查,成为早期诊断此类疾病的唯一手段。笔者拟就妊娠期疾病及其相关临床诊断指标的参考值范围的研究动态和争议进行阐述,以期为妊娠期甲状腺疾病的诊治工作提供参考。

Gestational thyroid disease has rapidly emerged as one of the most common diseases during pregnancy. There are various of causes, including an increase in prenatal and pregnancy examinations strategies, enlarging of checkup scope and changes of iodine nutritional status in pregnant women. With the accumulation of serum human chorionic gonadotropin (hCG) and estrogen concentrations, blood volume and the strengthening glomerular filtration, the process of pregnancy could have substantial impacts on thyroid functions. The relation between thyroid disorders and adverse pregnancy outcomes has been demonstrated in a great deal of analyses and researches. Thyroxine deficient diseases in pregnant women, including overt hypothyroidism (OH), subclinical hypothyroidism (SCH) and isolated hypothyroidism (IH), do bring about neuropsychological dysplasia of the offspring due to the critical value of thyroid hormone in neuronal migration and myelin formation of fetal brain tissues. The clinical manifestations and signs of early and (or) subclinical gestational thyroid diseases are often overlaped with the physiological manifestations of pregnancy, so laboratory testing on thyroid functions always become the only means for the diagnosis of gestational thyroid diseases. We would review on the research status and controversial focus of gestational thyroid diseases and reference ranges of related diagnostic indexes, to provide references for the diagnosis and treatment of thyroid diseases pregnancy.

图1 妊娠期血清hCG水平与血清TSH水平动态关系图
表1 中国孕妇血清TSH、FT4参考值范围(P2.5P97.5)
表2 中国孕妇血清FT4参考值范围的P5P10(pmol/L)
[1]
Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis[J]. N Engl J Med, 1989, 321(1): 13-16.
[2]
Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child[J]. N Engl J Med, 1999, 341(8): 549-555.
[3]
de Escobar GM, Obregón MJ, del Rey FE. Maternal thyroid hormones early in pregnancy and fetal brain development[J]. Best Pract Res Clin Endocrinol Metab, 2004, 18(2): 225-248.
[4]
Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab,2007,92(8 Suppl): S1-S47.
[5]
Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum[J]. Thyroid, 2011, 21(10): 1081-1125.
[6]
中华医学会内分泌学分会,中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南[J]. 中华内分泌代谢杂志,2012, 28(5): 354-371.
[7]
De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2012, 97(8): 2543-2565.
[8]
Lazarus J, Brown RS, Daumerie C, et al. 2014 European Thyroid Association Guidelines for the management of subclinical hypothyroidism in pregnancy and in children[J]. Eur Thyroid J, 2014, 3(2): 76-94.
[9]
Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum[J]. Thyroid, 2017, 27(3): 315-389.
[10]
Stagnaro-Green A. Clinical guidelines: thyroid and pregnancy time for universal screening? [J]. Nat Rev Endocrinol, 2017, 13(4): 192-194.
[11]
Gronowski AM, Haddow J, Kilpatrick S, et al. Thyroid function during pregnancy: who and how should we screen? [J]. Clin Chem, 2012, 58(10): 1397-1401.
[12]
Medici M, Korevaar TI, Visser WE, et al. Thyroid function in pregnancy: what is normal? [J]. Clin Chem, 2015, 61(5): 704-713.
[13]
Akarsu S, Akbiyik F, Karaismailoglu E, et al. Gestation specific reference intervals for thyroid function tests in pregnancy[J]. Clin Chem Lab Med, 2016, 54(8): 1377-1383.
[14]
Lapthorn AJ, Harris DC, Littlejohn A, et al. Crystal structure of human chorionic gonadotropin[J]. Nature, 1994, 369(6480): 455-461.
[15]
Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology[J]. Endocr Rev, 1997, 18(3): 404-433.
[16]
Berghout A, Wiersinga W. Thyroid size and thyroid function during pregnancy: an analysis[J]. Eur J Endocrinol, 1998, 138(5): 536-542.
[17]
Vermiglio F, Lo Presti VP, Moleti M, et al. Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries[J]. J Clin Endocrinol Metab, 2004, 89(12): 6054-6060.
[18]
Li CY, Shan ZY, Teng WP, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? [J]. J Clin Endocrinol Metab, 2014, 99(1): 73-79.
[19]
Negro R, Mestman JH. Thyroid disease in pregnancy[J]. Best Pract Res Clin Endocrinol Metab, 2011, 25(6): 927-943.
[20]
Shan ZY, Chen YY, Teng WP, et al. A study for maternal thyroid hormone deficiency during the first half of pregnancy in China[J]. Eur J Clin Invest, 2009, 39(1): 37-42.
[21]
Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy[J]. Thyroid, 2002, 12(1): 63-68.
[22]
Leung AS,Millar LK, Koonings PP, et al. Perinatal outcome in hypothyroid pregnancies[J]. Obstet Gynecol, 1993, 81(3): 349-353.
[23]
Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening[J]. J Med Screen, 2000, 7(3): 127-130.
[24]
Cooper DS, Biondi B. Subclinical thyroid disease[J]. Lancet, 2012, 379(9821): 1142-1154.
[25]
Lazarus JH. Thyroid function in pregnancy[J]. Br Med Bull, 2011, 97(1): 137-148.
[26]
Su PY, Huang K, Hao JH, et al. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China[J]. J Clin Endocrinol Metab, 2011, 96(10): 3234-3241.
[27]
Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes[J]. Obstet Gynecol, 2005, 105(2): 239-245.
[28]
Benhadi N, Wiersinga WM, Reitsma JB, et al. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death[J]. Eur J Endocrinol, 2009, 160(6): 985-991.
[29]
张建平,杨春凤. 复发性自然流产诊治若干问题[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(3): 292-296.
[30]
薛海波,李元宾,滕卫平,等. 妊娠早期母亲亚临床甲状腺功能减退症对其后代脑发育影响的前瞻性研究[J]. 中华内分泌代谢杂志,2010, 26(11): 916-920.
[31]
d′Herbomez M, Forzy G, Gasser F, et al. Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations[J]. Clin Chem Lab Med, 2003, 41(7): 942-947.
[32]
Dosiou C, Medici M. Isolated maternal hypothyroxinemia during pregnancy: knowns and unknowns[J]. Eur J Endocrinol, 2017, 176(1): R21-R38.
[33]
Lazarus J. Thyroid regulation and dysfunction in the pregnant patient[EB/OL]. (2016-07-21) [2017-08-10].

URL    
[34]
Shan Z, Chen L, Lian X, et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities[J]. Thyroid, 2016, 26(8): 1125-1130.
[35]
Stagnaro-Green A, Roman SH, Cobin RH, et al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies[J]. JAMA, 1990, 264(11): 1422-1425.
[36]
Iravani AT, Saeedi MM, Pakravesh J, et al. Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study[J]. Endocr Pract,2008,14(4):458-464.
[37]
Thangaratinam S, Tan A, Knox E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: Meta-analysis of evidence[J]. BMJ, 2011, 342: d2616.
[38]
Nicholson WK, Robinson KA, Smallridge RC, et al. Prevalence of postpartum thyroid dysfunction: a quantitative review[J]. Thyroid, 2006, 16(6): 573-582.
[39]
Alvarez-Marfany M, Roman SH, Drexler AJ, et al. Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus[J]. J Clin Endocrinol Metab, 1994, 79(1): 10-16.
[40]
Elefsiniotis IS, Vezali E, Pantazis KD, et al. Post-partum thyroiditis in women with chronic viral hepatitis[J]. J Clin Virol, 2008, 41(4): 318-319.
[41]
Stagnaro-Green A, Akhter E, Yim C, et al. Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery[J]. Lupus, 2011, 20(7): 690-699.
[42]
Zimmermann MB, Andersson M. Update on iodine status worldwide[J]. Curr Opin Endocrinol Diabetes Obes, 2012, 19(5): 382-387.
[43]
李阳桦,任海林,王全意,等. 2014年北京市碘营养监测结果分析[J]. 预防医学情报杂志,2015, 31(7): 497-500.
[44]
Vaidya B, Anthony S, Bilous M, et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? [J]. J Clin Endocrinol Metab, 2007, 92(1): 203-207.
[45]
Negro R, Schwartz A, Gismondi R, et al. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy[J]. J Clin Endocrinol Metab, 2010, 95(4): 1699-1707.
[46]
Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease[J]. Thyroid, 2003, 13(1): 3-126.
[47]
Boyd JC. Defining, establishing, and verifying reference intervals in the clinical laboratory, approved guideline. 3rd ed[M]. Wayne PA: Clinical and Laboratory Standards Institute, 2010.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[3] 唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[4] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[5] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[6] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[7] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[8] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[9] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[10] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[11] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[12] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[13] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[14] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[15] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?